Copyright © 2005, European Society of Cardiology
Autologous myoblast transplantation after myocardial infarction increases the inducibility of ventricular arrhythmias
L'Institut du Thorax INSERM U533, Faculté de Médecine, Nantes, France
PIMESP, CHU Nantes, France
INSERM U652, Paris
Service de Biochimie, CHU Nantes, France
Service d'Anatomo-pathologie, CHU Nantes, France
* Corresponding author. L'Institut du Thorax INSERM U533, Faculté de Médecine, 1 rue Gaston Veil, F-44035 Nantes cedex 1, France. Tel.: +33 2 40 41 29 91; fax: +33 2 40 41 29 50. Email address: patricia.lemarchand{at}nantes.inserm.fr
Background: Small scale clinical trials suggested the feasibility and the efficacy of autologous myoblast transplantation to improve ventricular function after myocardial infarction. However, these trials were hampered by unexpected episodes of life-threatening ventricular tachyarrhythmias (VT). We investigated cardiac electrical stability after myoblast transplantation to the myocardium.
Methods and results: Seven days after coronary ligation, Wistar rats were randomized into 3 groups: a control group receiving no further treatment, a vehicle group injected with culture medium into the infarcted myocardium, and a myoblast group injected with autologous myoblasts. Holter monitoring did not discriminate the myoblast from the vehicle groups. Programmed Electrical Stimulation (PES) was performed to evaluate further a cardiac substrate for arrhythmia susceptibility. The occurrence of sustained VT during PES was similar in control and vehicle groups (5/17 and 4/19 rats, respectively; p=0.50). In contrast, 13/20 rats (65%) from the myoblast group showed at least one episode of sustained VT during PES (p<0.05 and p<0.005 versus control and vehicle groups). As a further control group, rats injected with autologous bone marrow mononuclear cells into the infarcted myocardium did not show increased susceptibility to PES.
Conclusions: In an infarcted rat model, myoblast transplantation but not bone marrow mononuclear cells or myocardial injection per se induces electrical ventricular instability. Because ventricular arrhythmias are life-threatening disorders, we suggest that such preclinical evaluation should be conducted for any new source of cells to be injected into the myocardium.
Time for primary review 21 days
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. Menasche Stem Cell Therapy for Heart Failure: Are Arrhythmias a Real Safety Concern? Circulation, May 26, 2009; 119(20): 2735 - 2740. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Q. Ly and S. Nattel Stem Cells Are Not Proarrhythmic: Letting the Genie out of the Bottle Circulation, April 7, 2009; 119(13): 1824 - 1831. [Full Text] [PDF] |
||||
![]() |
Q. Zhao, Y. Sun, L. Xia, A. Chen, and Z. Wang Randomized Study of Mononuclear Bone Marrow Cell Transplantation in Patients With Coronary Surgery Ann. Thorac. Surg., December 1, 2008; 86(6): 1833 - 1840. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Gavira, G. Abizanda, M. Perez-Ilzarbe, D. Martinez-Caro, E. Nasarre, A. Perez-Ruiz, and F. Prosper Skeletal myoblasts for cardiac repair in animal models Eur. Heart J. Suppl., December 1, 2008; 10(suppl_K): K11 - K15. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Baldazzi, E. Jorgensen, R. S. Ripa, and J. Kastrup Release of biomarkers of myocardial damage after direct intramyocardial injection of genes and stem cells via the percutaneous transluminal route Eur. Heart J., August 1, 2008; 29(15): 1819 - 1826. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Menasche, O. Alfieri, S. Janssens, W. McKenna, H. Reichenspurner, L. Trinquart, J.-T. Vilquin, J.-P. Marolleau, B. Seymour, J. Larghero, et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial: First Randomized Placebo-Controlled Study of Myoblast Transplantation Circulation, March 4, 2008; 117(9): 1189 - 1200. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Hashemi, S. Ghods, F. D. Kolodgie, K. Parcham-Azad, M. Keane, D. Hamamdzic, R. Young, M. K. Rippy, R. Virmani, H. Litt, et al. A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction Eur. Heart J., January 2, 2008; 29(2): 251 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Fotuhi, Y.-H. Song, and E. Alt Electrophysiological consequence of adipose-derived stem cell transplantation in infarcted porcine myocardium Europace, December 1, 2007; 9(12): 1218 - 1221. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fukushima, A. Varela-Carver, S. R. Coppen, K. Yamahara, L. E. Felkin, J. Lee, P. J.R. Barton, C. M.N. Terracciano, M. H. Yacoub, and K. Suzuki Direct Intramyocardial But Not Intracoronary Injection of Bone Marrow Cells Induces Ventricular Arrhythmias in a Rat Chronic Ischemic Heart Failure Model Circulation, May 1, 2007; 115(17): 2254 - 2261. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Zebedin, M. Mille, M. Speiser, T. Zarrabi, W. Sandtner, B. Latzenhofer, H. Todt, and K. Hilber C2C12 skeletal muscle cells adopt cardiac-like sodium current properties in a cardiac cell environment Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H439 - H450. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Wu, Y. L. Liu, B. Zhou, and Z. C. Han Cellular therapy and myocardial tissue engineering: the role of adult stem and progenitor cells Eur. J. Cardiothorac. Surg., November 1, 2006; 30(5): 770 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kolossov, T. Bostani, W. Roell, M. Breitbach, F. Pillekamp, J. M. Nygren, P. Sasse, O. Rubenchik, J. W. U. Fries, D. Wenzel, et al. Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium J. Exp. Med., October 2, 2006; 203(10): 2315 - 2327. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Gavira, M. Perez-Ilzarbe, G. Abizanda, A. Garcia-Rodriguez, J. Orbe, J. A. Paramo, M. Belzunce, G. Rabago, J. Barba, J. Herreros, et al. A comparison between percutaneous and surgical transplantation of autologous skeletal myoblasts in a swine model of chronic myocardial infarction Cardiovasc Res, September 1, 2006; 71(4): 744 - 753. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Kolettis Arrhythmogenesis after cell transplantation post-myocardial infarction. Four burning questions-And some answers Cardiovasc Res, February 1, 2006; 69(2): 299 - 301. [Full Text] [PDF] |
||||








